This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
Active as of 2021-11-04 |
<ActivityDefinition xmlns="http://hl7.org/fhir">
<id value="213"/>
<meta>
<versionId value="7"/>
<lastUpdated value="2023-12-05T12:52:51.103Z"/>
<profile
value="http://hl7.org/fhir/uv/ebm/StructureDefinition/recommendation-action"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: ActivityDefinition</b><a name="213"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ActivityDefinition "213" Version "7" Updated "2023-12-05 12:52:51+0000" </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-recommendation-action.html">RecommendationAction</a></p></div><p><b>StructureDefinition Work Group</b>: cds</p><p><b>url</b>: <code>https://fevir.net/resources/ActivityDefinition/213</code></p><p><b>identifier</b>: FEvIR Object Identifier: 213</p><p><b>version</b>: 1.0.0-ballot</p><p><b>name</b>: IV_remdesivir_200_mg_then_100_mg_day_for_9_days</p><p><b>title</b>: IV remdesivir 200 mg then 100 mg/day for 9 days</p><p><b>status</b>: active</p><p><b>date</b>: 2021-11-04 13:34:54+0000</p><p><b>publisher</b>: HL7 International / Clinical Decision Support</p><p><b>contact</b>: HL7 International / Clinical Decision Support: <a href="http://www.hl7.org/Special/committees/dss">http://www.hl7.org/Special/committees/dss</a></p><p><b>description</b>: This example uses the Dosage datatype to represent dosing for IV remdesivir.</p><p><b>jurisdiction</b>: World <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (m49.htm#001)</span></p><p><b>copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p><p><b>author</b>: Brian S. Alper: </p><h3>RelatedArtifacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Citation</b></td></tr><tr><td style="display: none">*</td><td>cite-as</td><td>IV remdesivir 200 mg then 100 mg/day for 9 days [ActivityDefinition]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 213. Revised 2021-11-04. Available at: https://fevir.net/resources/ActivityDefinition/213. Computable resource at: https://fevir.net/resources/ActivityDefinition/213.</td></tr></table><p><b>kind</b>: MedicationRequest</p><p><b>code</b>: Remdesivir 100 mg Injection <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-rxNorm.html">RxNorm</a>#2284960)</span></p><p><b>intent</b>: order</p><blockquote><p><b>dosage</b></p><p><b>sequence</b>: 1</p><p><b>text</b>: IV remdesivir 200 mg once on day 1</p><p><b>route</b>: Intravenous use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#47625008)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote></blockquote><blockquote><p><b>dosage</b></p><p><b>sequence</b>: 2</p><p><b>text</b>: IV remdesivir 100 mg once daily on days 2 through 10</p><p><b>route</b>: Intravenous use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#47625008)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote></blockquote></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="cds"/>
</extension>
<url value="https://fevir.net/resources/ActivityDefinition/213"/>
<identifier>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
<code value="ACSN"/>
<display value="Accession ID"/>
</coding>
<text value="FEvIR Object Identifier"/>
</type>
<system value="https://fevir.net"/>
<value value="213"/>
<assigner>
<display value="Computable Publishing LLC"/>
</assigner>
</identifier>
<version value="1.0.0-ballot"/>
<name value="IV_remdesivir_200_mg_then_100_mg_day_for_9_days"/>
<title value="IV remdesivir 200 mg then 100 mg/day for 9 days"/>
<status value="active"/>
<date value="2021-11-04T13:34:54.626Z"/>
<publisher value="HL7 International / Clinical Decision Support"/>
<contact>
<name value="HL7 International / Clinical Decision Support"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/dss"/>
</telecom>
</contact>
<description
value="This example uses the Dosage datatype to represent dosing for IV remdesivir."/>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
<display value="World"/>
</coding>
</jurisdiction>
<copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
<author>
<name value="Brian S. Alper"/>
</author>
<relatedArtifact>
<type value="cite-as"/>
<citation
value="IV remdesivir 200 mg then 100 mg/day for 9 days [ActivityDefinition]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 213. Revised 2021-11-04. Available at: https://fevir.net/resources/ActivityDefinition/213. Computable resource at: https://fevir.net/resources/ActivityDefinition/213."/>
</relatedArtifact>
<kind value="MedicationRequest"/>
<code>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<code value="2284960"/>
<display value="Remdesivir 100 mg Injection"/>
</coding>
</code>
<intent value="order"/>
<dosage>
<sequence value="1"/>
<text value="IV remdesivir 200 mg once on day 1"/>
<route>
<coding>
<system value="http://snomed.info/sct"/>
<code value="47625008"/>
<display value="Intravenous use"/>
</coding>
</route>
<doseAndRate>
<doseQuantity>
<value value="2"/>
</doseQuantity>
</doseAndRate>
</dosage>
<dosage>
<sequence value="2"/>
<text value="IV remdesivir 100 mg once daily on days 2 through 10"/>
<route>
<coding>
<system value="http://snomed.info/sct"/>
<code value="47625008"/>
<display value="Intravenous use"/>
</coding>
</route>
<doseAndRate>
<doseQuantity>
<value value="1"/>
</doseQuantity>
</doseAndRate>
</dosage>
</ActivityDefinition>
IG © 2022+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot based on FHIR 5.0.0. Generated 2023-12-17
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change